HCWB Insider Trading Activity and SEC Form 4 Filings
HCWB insider trading summary
Over the past 12 months, insiders at HCW Biologics Inc. (HCWB) reported 6 open-market purchases worth $530K by 4 insiders and no sales on SEC Form 4. Net insider buying was $530K.
Latest HCWB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Lee Flowers | SVP of Business Development | Buy | $20K (7,736 @ $2.58) |
| Jul 29, 2026 | Scott T Garrett | Director | Buy | $20K (7,736 @ $2.58) |
| Jul 29, 2026 | Hing C Wong | Chief Executive Officer | Buy | $60K (23,210 @ $2.58) |
| May 22, 2026 | Scott T Garrett | Director | Buy | $250K (177,936 @ $1.41) |
| May 22, 2026 | Rebecca Byam | Chief Financial Officer | Buy | $20K (14,235 @ $1.41) |
| May 22, 2026 | Hing C Wong | Chief Executive Officer | Buy | $160K (113,879 @ $1.41) |
| May 16, 2025 | Hing C Wong | Chief Executive Officer | Buy | $60K (8,054 @ $7.45) |
| May 16, 2025 | Scott T Garrett | Insider | Buy | $100K (13,423 @ $7.45) |
| May 16, 2025 | Gary M Winer | Insider | Buy | $10K (1,342 @ $7.45) |
| May 8, 2025 | Rick S. Greene | Insider | Buy | $25K (962 @ $26.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.